108
Participants
Start Date
December 13, 2023
Primary Completion Date
July 7, 2028
Study Completion Date
July 7, 2028
Acalabrutinib
Investigational Product
Venetoclax
Investigator Product
Rituximab
Investigator Product
Research Site, Sydney
Research Site, Heidelberg
Research Site, Nedlands
Research Site, Stony Brook
Research Site, Philadelphia
Research Site, Madrid
Research Site, Cleveland
Research Site, Houston
Research Site, Hackensack
Research Site, Kogarah
Research Site, Porto Alegre
Research Site, Rio de Janeiro
Research Site, São Paulo
Research Site, São Paulo
Research Site, Edmonton
Research Site, Vancouver
Research Site, Halifax
Research Site, Barrie
Research Site, Toronto
Research Site, Montreal
Research Site, Gdynia
Research Site, Krakow
Research Site, Warsaw
Research Site, Birmingham
Research Site, Gloucester
Research Site, London
Research Site, Norwich
Research Site, Nottingham
Research Site, Plymouth
Lead Sponsor
AstraZeneca
INDUSTRY